Two years of the COVID-19 pandemic in the population of Czech patients with inflammatory bowel disease treated with bio-logical therapy - experience of the tertiary IBD center

Abstract

Inflammatory bowel disease (IBD) may be associated with a more severe course of infections and a different response to vaccination, especially in complicated IBD course and in association with immune-modifying IBD treatment. The aim of this study was to describe COVID-19 pandemic during years 2020-2022 in IBD patients with long-term biological therapy.

Keywords

• inflammatory bowel disease
• Crohn’s disease
• ulcerative colitis
• COVID-19
• SARS-CoV-2
• vaccination
• biological therapy